PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
16603182-9	2006	The cumulative effects of EPO on BMI induced and increase in capillary number and artery enlargement.	bmi	33-36	erythropoietin	Homo sapiens	26-29
24359475-7	2014	One SNP in PPARGC1A, rs12640088, had a significant interaction with BMI.	bmi	68-71	PPARG coactivator 1 alpha	Homo sapiens	11-19
16518534-6	2006	BMI resulted in lower levels of VEGF and bFGF, and this fall is the hallmark of the effectiveness of BMI in the treatment of peripheral artery disease.	bmi	0-3	vascular endothelial growth factor A	Homo sapiens	32-36
16518534-6	2006	BMI resulted in lower levels of VEGF and bFGF, and this fall is the hallmark of the effectiveness of BMI in the treatment of peripheral artery disease.	bmi	0-3	fibroblast growth factor 2	Homo sapiens	41-45
15564705-10	2004	CONCLUSIONS: It is likely that the number of implanted CD34-positive cells is one of the primary factors that influence the clinical efficacy of BMI.	bmi	145-148	CD34 molecule	Homo sapiens	55-59
34105470-4	2021	RESULTS: Compared with non-BMI group, the red blood cell distribution width, C-reactive protein, erythrocyte sedimentation rate, D-dimer, lactate dehydrogenase, alkaline phosphatase, beta2-microglobulin, transferrin, CA153, CA125, and soluble interleukin-2 receptor (sIL-2R) levels were increased while platelet (PLT) count was decreased in BMI group, and the difference was statistically significant (P<0.05).	bmi	341-344	C-reactive protein	Homo sapiens	77-95
34105470-4	2021	RESULTS: Compared with non-BMI group, the red blood cell distribution width, C-reactive protein, erythrocyte sedimentation rate, D-dimer, lactate dehydrogenase, alkaline phosphatase, beta2-microglobulin, transferrin, CA153, CA125, and soluble interleukin-2 receptor (sIL-2R) levels were increased while platelet (PLT) count was decreased in BMI group, and the difference was statistically significant (P<0.05).	bmi	341-344	beta-2-microglobulin	Homo sapiens	183-202
34105470-4	2021	RESULTS: Compared with non-BMI group, the red blood cell distribution width, C-reactive protein, erythrocyte sedimentation rate, D-dimer, lactate dehydrogenase, alkaline phosphatase, beta2-microglobulin, transferrin, CA153, CA125, and soluble interleukin-2 receptor (sIL-2R) levels were increased while platelet (PLT) count was decreased in BMI group, and the difference was statistically significant (P<0.05).	bmi	341-344	transferrin	Homo sapiens	204-215
34105470-4	2021	RESULTS: Compared with non-BMI group, the red blood cell distribution width, C-reactive protein, erythrocyte sedimentation rate, D-dimer, lactate dehydrogenase, alkaline phosphatase, beta2-microglobulin, transferrin, CA153, CA125, and soluble interleukin-2 receptor (sIL-2R) levels were increased while platelet (PLT) count was decreased in BMI group, and the difference was statistically significant (P<0.05).	bmi	341-344	mucin 1, cell surface associated	Homo sapiens	217-222
34105470-4	2021	RESULTS: Compared with non-BMI group, the red blood cell distribution width, C-reactive protein, erythrocyte sedimentation rate, D-dimer, lactate dehydrogenase, alkaline phosphatase, beta2-microglobulin, transferrin, CA153, CA125, and soluble interleukin-2 receptor (sIL-2R) levels were increased while platelet (PLT) count was decreased in BMI group, and the difference was statistically significant (P<0.05).	bmi	341-344	mucin 16, cell surface associated	Homo sapiens	224-229